| Product Type | Impurity Standards |
| CAT. No. | MRL-M47004 |
| CAS. No. | NA |
| Mol. Formula | C22H25N7O9 |
| Mol. Weight | 531.48 |
| Synonyms | NA |
| Chemical Name | N-(5,8-Dihydroxy-4-((2-((2-hydroxyethyl)(nitroso)amino)ethyl)(nitroso)amino)-9,10-dioxo-9,10-dihydroanthracen-1-yl)-N-(2-((2-hydroxyethyl)amino)ethyl)nitrous amide |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Please Enquire |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Mitoxantrone. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Mitoxantrone is a chemotherapy medication used in the treatment of certain cancers, including metastatic breast cancer, acute nonlymphocytic leukemia (ANLL), and advanced prostate cancer. It belongs to the anthracenedione class of antineoplastic agents. Mitoxantrone works by interfering with DNA replication and repair processes, ultimately inhibiting the growth of cancer cells. It is often administered intravenously and may be part of a combination chemotherapy regimen. Mitoxantrone is typically reserved for cases where other treatment options have proven ineffective, and its benefits are weighed against potential risks for each individual patient. Buy high quality N,N,N-Trinitroso Mitoxantrone from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N,N,N-Trinitroso Mitoxantrone